PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3547923-0	1987	Interleukin 2 response inhibition following donor specific transfusions given with azathioprine.	Azathioprine	83-95	interleukin 2	Homo sapiens	0-13	
3495914-0	1987	Initial characterization of humoral IL-2 response inhibition following donor-specific transfusions under azathioprine immunosuppression.	Azathioprine	105-117	interleukin 2	Homo sapiens	36-40	
3495914-1	1987	A previous study indicated that noncompetitive humoral inhibition of IL-2-induced proliferation was a frequent consequence of donor-specific transfusions under azathioprine immunosuppression.	Azathioprine	160-172	interleukin 2	Homo sapiens	69-73	
2947355-0	1986	Modulation of the response to interleukin 2 in recipients of donor-specific transfusions under azathioprine immunosuppression.	Azathioprine	95-107	interleukin 2	Homo sapiens	30-43	
2947355-1	1986	The effect of plasma from recipients of donor-specific transfusions given under azathioprine immunosuppression (DST+A) on the response to IL-2 was examined.	Azathioprine	80-92	interleukin 2	Homo sapiens	138-142	
2931095-0	1985	Effect of interleukin-2 on the inhibition of the human mixed lymphocyte reaction (MLR) by azathioprine.	Azathioprine	90-102	interleukin 2	Homo sapiens	10-23	
2931095-1	1985	The effect of interleukin-2 on the response of the human MLR to azathioprine was studied.	Azathioprine	64-76	interleukin 2	Homo sapiens	14-27	
2931095-3	1985	Only partial relief (16%) of azathioprine (36 microM) inhibition was found in the interleukin-2 treated MLR compared with azathioprine treatment alone.	Azathioprine	29-41	interleukin 2	Homo sapiens	82-95	
2931095-4	1985	However, [3H]-thymidine incorporation by azathioprine (36 microM) + interleukin-2 treated MLR was 4.3 times greater than that exposed to azathioprine alone.	Azathioprine	137-149	interleukin 2	Homo sapiens	68-81	
30748107-14	2019	By ELISA, IL-2 and IL-13 were significantly lower with topical steroid, AZA, and 6-MP treatment (p = 0.012 and p < 0.001).	Azathioprine	72-75	interleukin 2	Homo sapiens	10-14	
7481481-12	1995	The addition of low doses of cytotoxic drugs (oral cyclophosphamide or azathioprine) resulted in an improvement in the capacity to absorb IL-2 and a reduction in spontaneous IL-1 production.	Azathioprine	71-83	interleukin 2	Homo sapiens	138-142	
30048737-6	2018	IL-2 production was reduced in response to treatment with well-known immunotoxicants cyclosporin A (CYA), dexamethasone (DEX), azathioprine (AZPR), methotrexate (MOT) and benzo(a)pyrene (BAP) but was not affected by treatment with cyclophosphamide (CYPH).	Azathioprine	127-139	interleukin 2	Homo sapiens	0-4	
30048737-6	2018	IL-2 production was reduced in response to treatment with well-known immunotoxicants cyclosporin A (CYA), dexamethasone (DEX), azathioprine (AZPR), methotrexate (MOT) and benzo(a)pyrene (BAP) but was not affected by treatment with cyclophosphamide (CYPH).	Azathioprine	141-145	interleukin 2	Homo sapiens	0-4	
15888259-5	2005	The combination of IFNbeta-1b with AZA resulted in a significant negative effect on the production of IL-2 (P=0.006), whereas TNF-alpha (P=0.02), IFN-gamma (P=0.03), IL-4 (P=0.2), and IL-10 (P=0.3) were not statistically impacted.	Azathioprine	35-38	interleukin 2	Homo sapiens	102-106	
20693061-6	1994	Other immunomodulatory compounds such as azathioprine (1 mug/ml) and tributyltin oxide (1 nm) caused a partial inhibition of IL-2 and/or IL-2 receptor mRNA within rodent mixed lymphocyte cultures.	Azathioprine	41-53	interleukin 2	Homo sapiens	125-129